Irvine Scientific looks to tap CAR-T growth with new media
Cell culture media manufacturer Irvine Scientific has launched a new xeno-free and serum-free medium that supports immunotherapy production.
Archives for January 21, 2015
Biosimilar mAbs may have tougher time winning US FDA approval says expert
So far most biosimilars filed in the US have been ‘low risk’ according to contractor BioOutsource, which warned that developers seeking approval for copycat mAbs face higher legal and regulatory hurdles than in Europe.
Teva: More biomanufacturing space needed to tap biologics opportunities
Teva must invest in its biomanufacturing network as the firm’s biologics aspirations grow beyond biosimilars, CEO Erez Vigodman told investors.
Antitope to produce manufacturing cell lines for two potential HIV vaccines
Abenza subsidiary Antitope has extended its relationship and will provide manufacturing cell lines for two developing HIV vaccines from the French National Institute of Health and Medical Research (INSERM); the National Health Agency for Research on AIDS...